ALKERMES reported 55.16M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4021M 259M
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Acorda Therapeutics ACOR:US $ 5.97M 1.77M
Amgen AMGN:US $ 1561M 157M
Biogen BIIB:US $ 753.9M 93.8M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Bristol Myers Squibb BMY:US $ 2471M 115M
Coherus Biosciences CHRS:US $ 9.37M 2.73M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Gilead Sciences GILD:US $ 1424M 1203M
H. Lundbeck A/S LUN:DC 845M 155M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Horizon Pharma HZNP:US $ 215.06M 26.45M
Intra Cellular Therapies ITCI:US $ 3.16M 0.62M
IONIS PHARMACEUT IONS:US $ 4.17M 1.94M
JAZZ PHA JAZZ:US $ 115.28M 20.87M
Johnson & Johnson JNJ:US $ 7598M 357M
Merk MRK:US $ 5334M 1507M
Nektar Therapeutics NKTR:US $ 5.32M 0.85M
Neurocrine Biosciences NBIX:US $ 4.6M 0.5M
Otsuka Holdings 4578:JP Y 126340M 10022M
Pfizer PFE:US $ 10010M 399M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Revance Therapeutics RVNC:US $ 7.89M 12K
Teva Pharmaceutical Industries TEVA:US $ 1859M 116M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M